{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-008562","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2024-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.130503+00:00","generated_at":"2026-06-06T23:28:53.636175+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"DH CEO Musslewhite steps down; Founder Krantz interim CEO; reaffirms Q4 guidance, issues 2024 preview","bullets":["CEO Robert Musslewhite resigned effective Jan 16, 2024; departure is without cause; receives 15 months accelerated vesting and up to $15K in legal fees.","Founder and Executive Chairman Jason Krantz appointed interim CEO, effective Jan 16, 2024; Board engaged search firm for permanent CEO.","Company reaffirms Q4 2023 guidance provided on Nov 3, 2023; preliminary 2024 guidance: revenue growth 5-7% YoY, Adj. EBITDA margin +~200 bps.","Krantz previously served as CEO from 2011 to Aug 2022, scaling the company to >$200M revenue and IPO in Sept 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-008562","json":"https://secwatch.observer/filing/0001193125-24-008562.json","markdown":"https://secwatch.observer/filing/0001193125-24-008562.md","text":"https://secwatch.observer/filing/0001193125-24-008562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/d683059d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:28:53.636175+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e13d2f85615bd0f3b609f89dd0ebd773461e1fd","claim":"Definitive Healthcare Corp. updated its the quarter ended December 31, 2023 guidance (reaffirmed).","evidence_excerpt":"On January 16, 2024, Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) issued a press release announcing the management changes described in Item 5.02 below and its reaffirmation of previously announced guidance for the quarter ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"22cb32f14c","claim":"Jason Krantz was appointed as Interim Chief Executive Officer at Definitive Healthcare Corp..","evidence_excerpt":"On January 12, 2024, the Company’s Board of Directors appointed Jason Krantz, the Company’s founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"3638af4734","claim":"Robert Musslewhite departed as Chief Executive Officer at Definitive Healthcare Corp..","evidence_excerpt":"On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors, effective January 16, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}